Sleep Medicine News

LAS VEGAS — Lesser-known cannabinoids are showing potential for treating neurological disease, inflammation, pain, cancer and infection, according to dermatologist Jeanette Jacknin, MD.

Symptoms of insomnia and sleep apnea were associated with a 56% increased risk for all-cause mortality, researchers reported in Sleep Epidemiology.

Heavy drinkers with symptoms of insomnia were less likely to experience alcohol-induced blackouts, researchers reported in Addictive Behaviors.

The digital therapeutic Somryst, which delivers cognitive behavior therapy for insomnia, induced a significant decrease in insomnia severity after 9 weeks, researchers reported in ClinicoEconomics and Outcomes Research.

In this edition, physicians should question patients with restless leg syndrome about cannabis use ; digital therapeutic improves symptoms of insomnia, anxiety and depression; more efficient sleep may benefit patients with fibromyalgia and insomnia and more.

CHARLOTTE, N.C. — Clinicians should consider biological sex when developing therapeutic strategies for military personnel with chronic sleep disorders caused by mild traumatic brain injury, according to a poster at the SLEEP meeting.

In this edition, temperature-controlled mattresses and pillows improve sleep; how overturning Roe v. Wade affects the field of neurology; college students’ cognition altered by changing sleep patterns and more.

CHARLOTTE, N.C. — Evaluation of nearly 9,000 study participants showed that sleep electroencephalograms contain decodable information about the risk for future incidence of mortality, dementia and other diseases.

CHARLOTTE, N.C. — Patients with restless leg syndrome may use cannabis to relieve symptoms, which should be documented by physicians when conducting patient history, researchers reported at the SLEEP meeting.

CHARLOTTE, N.C. — Study results indicate that better sleep efficiency in patients with fibromyalgia and insomnia may help improve their pain-related disability, according to a poster presented at the SLEEP meeting.